Zkusit zdarma
Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc.

PRAX
Cena:
$ 343.56
-7.00 (-2.00%)
Valuace
70
Růst
53
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Praxis Precision Medicines, Inc. (PRAX) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Praxis Precision Medicines, Inc. (PRAX) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

21:30 12-05-2026

Praxis Precision Medicines, Inc. (PRAX) Presents at Bank of America Global Healthcare Conference 202...

Praxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings Call Transcript

Praxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings Call Transcript

13:21 09-05-2026

Praxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings Call Transcript...

Praxis Precision Medicines Q1 Earnings Call Highlights

Praxis Precision Medicines Q1 Earnings Call Highlights

16:15 08-05-2026

Praxis Precision Medicines NASDAQ: PRAX said it is preparing for two potential U.S. product launches...

Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results

Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results

8:00 07-05-2026

FDA accepted the new drug application (NDA) for ulixacaltamide in Essential Tremor with a PDUFA targ...

Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference

Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference

16:01 04-05-2026

BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully in...

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Recommendation of “Buy” by Brokerages

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Recommendation of “Buy” by Brokerages

2:31 24-04-2026

Shares of Praxis Precision Medicines, Inc. (NASDAQ: PRAX - Get Free Report) have been assigned an av...

Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor

Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor

7:30 14-04-2026

FDA assigned PDUFA target action date of January 29, 2027 No advisory committee meeting expected BOS...

Praxis: Strong Buy As Relutrigine Submission Accepted Plus Expansion Potential

Praxis: Strong Buy As Relutrigine Submission Accepted Plus Expansion Potential

16:10 06-04-2026

Praxis Precision Medicines, Inc. remains a Strong Buy, driven by two NDA submissions and pipeline ex...

Praxis Stock Rises After Elsunersen Shows 77% Seizure Reduction In Trial

Praxis Stock Rises After Elsunersen Shows 77% Seizure Reduction In Trial

9:08 06-04-2026

Praxis said elsunersen demonstrated a placebo-adjusted seizure reduction from baseline of 77% (p=0.0...

Praxis Precision Medicines Announces Positive Results from the EMBRAVE Part A Trial of Elsunersen in Patients with SCN2A Early-Onset Developmental and Epileptic Encephalopathy

Praxis Precision Medicines Announces Positive Results from the EMBRAVE Part A Trial of Elsunersen in Patients with SCN2A Early-Onset Developmental and Epileptic Encephalopathy

8:00 06-04-2026

Elsunersen demonstrated placebo-adjusted seizure reduction from baseline of 77% (p=0.015) 71% of els...

SG Americas Securities LLC Cuts Position in Praxis Precision Medicines, Inc. $PRAX

SG Americas Securities LLC Cuts Position in Praxis Precision Medicines, Inc. $PRAX

4:59 04-04-2026

SG Americas Securities LLC lessened its position in Praxis Precision Medicines, Inc. (NASDAQ: PRAX) ...

Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

16:01 30-03-2026

FDA assigned PDUFA target action date of September 27, 2026 BOSTON, March 30, 2026 (GLOBE NEWSWIRE) ...

This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter

This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter

18:23 16-03-2026

Cormorant Asset Management sold 50,000 shares of PRAX in the fourth quarter; the estimated trade siz...

Praxis Precision Medicines, Inc. $PRAX Shares Sold by B Group Inc.

Praxis Precision Medicines, Inc. $PRAX Shares Sold by B Group Inc.

3:07 14-03-2026

B Group Inc. trimmed its holdings in Praxis Precision Medicines, Inc. (NASDAQ: PRAX) by 10.0% during...

Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline

Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline

10:14 13-03-2026

Deerfield Management Company increased its PRAX stake by 62,500 shares in the fourth quarter; the es...

Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings

Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings

9:23 13-03-2026

Driehaus Capital Management added 432,510 shares of PRAX in the fourth quarter; the estimated value ...

Praxis Precision Medicines, Inc. (PRAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Praxis Precision Medicines, Inc. (PRAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

16:45 06-03-2026

Praxis Precision Medicines, Inc. (PRAX) Presents at TD Cowen 46th Annual Health Care Conference Tran...

Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year

Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year

13:29 23-02-2026

Baker Bros. Advisors LP added 437,000 shares of Praxis Precision Medicines in the fourth quarter; th...

Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million

Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million

14:16 22-02-2026

Perceptive Advisors purchased 431,432 Praxis Precision Medicines shares in the fourth quarter; the e...

Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results

Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results

12:10 20-02-2026

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) reported a wider-than-expected loss for the fourth q...

close

PRAXIS PRECISION MEDICINES TO REPORT FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS ON THURSDAY, FEBRUARY 19, 2026, AND PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

09-02-2026
BOSTON, FEB. 09, 2026 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A FULLY I...
Více zde

PRAXIS PRECISION MEDICINES, INC. ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

04-02-2026
BOSTON, FEB. 04, 2026 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A FULLY I...
Více zde

SEQSTER ANNOUNCES EXPANDED PARTNERSHIP WITH PRAXIS PRECISION MEDICINES TO ACCELERATE CLINICAL TRIALS IN CNS DISORDERS

02-02-2026
SAN DIEGO & BOSTON--(BUSINESS WIRE)--SEQSTER, THE LEADING HEALTHCARE TECHNOLOGY COMPANY AND THE DATA...
Více zde

PRAXIS PRECISION MEDICINES, INC. ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

09-01-2026
BOSTON, JAN. 09, 2026 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A CLINICA...
Více zde

PRAXIS PRECISION MEDICINES FURTHER POSITIONED FOR NEXT-PHASE GROWTH WITH KEY BOARD AND EXECUTIVE APPOINTMENTS

08-01-2026
BOSTON, JAN. 08, 2026 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A CLINICA...
Více zde

PRAXIS PRECISION MEDICINES, INC. ANNOUNCES PRICING OF $575 MILLION PUBLIC OFFERING

06-01-2026
BOSTON, JAN. 06, 2026 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A CLINICA...
Více zde

PRAXIS PRECISION MEDICINES, INC. ANNOUNCES PROPOSED PUBLIC OFFERING

06-01-2026
BOSTON, JAN. 06, 2026 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A CLINICA...
Více zde

PRAXIS PRECISION MEDICINES ANNOUNCES THE FDA HAS GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR ULIXACALTAMIDE HCL IN ESSENTIAL TREMOR

29-12-2025
THE BREAKTHROUGH THERAPY DESIGNATION WAS GRANTED BASED ON THE POSITIVE TOPLINE RESULTS FROM THE ESSE...
Více zde

PRAXIS PRECISION MEDICINES ANNOUNCES PLANS TO FILE AN NDA FOR RELUTRIGINE IN SCN2A AND SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES IN EARLY 2026

11-12-2025
EMBOLD DATA TO SERVE AS BASIS OF EFFICACY AND SAFETY FOLLOWING DISCUSSION WITH THE FDA EMBOLD DATA T...
Více zde

PRAXIS PRECISION MEDICINES ANNOUNCES ALIGNMENT WITH FDA ON SIMPLIFIED AND ACCELERATED REGISTRATIONAL PATHWAY FOR ELSUNERSEN IN EARLY ONSET SCN2A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY

09-12-2025
CLEAR RECOGNITION OF HIGH UNMET NEED AND URGENCY FOR THE SCN2A COMMUNITY AND PLAUSIBILITY OF THE MEC...
Více zde

PRAXIS PRECISION MEDICINES ANNOUNCES POSITIVE RESULTS FROM EMBOLD STUDY FOR RELUTRIGINE IN SCN2A AND SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES

04-12-2025
SUCCESSFUL INTERIM ANALYSIS TRIGGERED EARLY STOP FOR EFFICACY TOPLINE STUDY RESULTS TO BE SHARED AT ...
Více zde

PRAXIS PRECISION MEDICINES ANNOUNCES POSITIVE PRE-NDA MEETING WITH FDA FOR ULIXACALTAMIDE IN ESSENTIAL TREMOR

04-12-2025
PRAXIS CONFIRMS PLANS TO SUBMIT THE ESSENTIAL TREMOR NDA FOR ULIXACALTAMIDE IN EARLY 2026 PRAXIS CON...
Více zde

PRAXIS PRECISION MEDICINES, INC. ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-12-2025
BOSTON, DEC. 03, 2025 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A CLINICA...
Více zde

PRAXIS PRECISION MEDICINES TO PARTICIPATE IN UPCOMING FIRESIDE CHAT

20-11-2025
BOSTON, NOV. 20, 2025 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES , INC. (NASDAQ: PRAX), A CLINIC...
Více zde

PRAXIS PRECISION MEDICINES, INC. ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

06-11-2025
BOSTON, NOV. 06, 2025 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A CLINICA...
Více zde

PRAXIS PRECISION MEDICINES, INC. ANNOUNCES PRICING OF $525 MILLION PUBLIC OFFERING

16-10-2025
BOSTON, OCT. 16, 2025 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A CLINICA...
Více zde

PRAXIS PRECISION MEDICINES, INC. ANNOUNCES PROPOSED PUBLIC OFFERING

16-10-2025
BOSTON, OCT. 16, 2025 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A CLINICA...
Více zde

PRAXIS PRECISION MEDICINES, INC. ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

02-10-2025
BOSTON, OCT. 02, 2025 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A CLINICA...
Více zde

RECODE THERAPEUTICS ANNOUNCES OVER $29 MILLION IN ADDITIONAL FINANCING TO ADVANCE GENETIC MEDICINES PIPELINE AND PROVIDES CORPORATE UPDATE

29-09-2025
MENLO PARK, CALIF.--(BUSINESS WIRE)--RECODE THERAPEUTICS, A CLINICAL-STAGE GENETIC MEDICINES COMPANY...
Více zde

PRAXIS ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING PRAXIS PRECISION MEDICINES, INC. ON BEHALF OF PRAXIS STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

15-09-2025
BRAGAR EAGEL & SQUIRE, P.C. LITIGATION PARTNER  BRANDON WALKER  ENCOURAGES INVESTORS WHO SUFFERED ...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PRAXIS PRECISION MEDICINES, INC. - PRAX

13-09-2025
NEW YORK , SEPT. 13, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTO...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PRAXIS PRECISION MEDICINES, INC. - PRAX

08-09-2025
NEW YORK , SEPT. 8, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

PRAXIS PRECISION MEDICINES TO PARTICIPATE IN SEPTEMBER INVESTOR CONFERENCES

04-09-2025
BOSTON, MASS., SEPT. 04, 2025 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES , INC. (NASDAQ: PRAX), ...
Více zde

PRAXIS PRECISION MEDICINES, INC. ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-09-2025
BOSTON, SEPT. 03, 2025 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A CLINIC...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PRAXIS PRECISION MEDICINES, INC. - PRAX

03-09-2025
NEW YORK , SEPT. 3, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PRAXIS PRECISION MEDICINES, INC. - PRAX

02-09-2025
NEW YORK, SEPT. 02, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PRAXIS PRECISION MEDICINES, INC. - PRAX

29-08-2025
NEW YORK, AUG. 29, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVES...
Více zde

PRAXIS MEDICINES TO PRESENT AT 36TH INTERNATIONAL EPILEPSY CONGRESS 2025 IN LISBON, SHOWCASING LATEST RADIANT STUDY DATA AND LEADING PRECISION EPILEPSY PIPELINE

25-08-2025
BOSTON, AUG. 25, 2025 (GLOBE NEWSWIRE) -- PRAXIS PRECISION MEDICINES, INC. (NASDAQ: PRAX), A CLINICA...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF PRAXIS PRECISION MEDICINES, INC. - PRAX

25-08-2025
NEW YORK, AUG. 25, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVES...
Více zde

PRAXIS ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING PRAXIS PRECISION MEDICINES, INC. ON BEHALF OF PRAXIS STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

23-08-2025
BRAGAR EAGEL & SQUIRE, P.C. LITIGATION PARTNER  BRANDON WALKER  ENCOURAGES INVESTORS WHO SUFFERED ...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-08 00:00:008-KStáhnout
2026-01-07 00:00:008-KStáhnout
2026-01-06 00:00:008-KStáhnout
2025-12-29 00:00:008-KStáhnout
2025-12-11 00:00:008-KStáhnout
2025-12-08 00:00:008-KStáhnout
2025-11-05 00:00:008-KStáhnout
2025-11-05 00:00:0010-QStáhnout
2025-10-21 01:00:008-KStáhnout
2025-10-21 00:00:008-KStáhnout
2025-10-16 01:00:008-KStáhnout
2025-10-16 00:00:008-KStáhnout
2025-09-05 01:00:008-KStáhnout
2025-09-05 00:00:008-KStáhnout
2025-08-04 01:00:008-KStáhnout
2025-08-04 01:00:0010-QStáhnout
2025-08-04 00:00:008-KStáhnout
2025-08-04 00:00:0010-QStáhnout
2025-07-17 01:00:008-KStáhnout
2025-07-17 00:00:008-KStáhnout
2025-06-27 01:00:008-KStáhnout
2025-06-27 00:00:008-KStáhnout
2025-05-02 01:00:008-KStáhnout
2025-05-02 01:00:0010-QStáhnout
2025-05-02 00:00:008-KStáhnout
2025-05-02 00:00:0010-QStáhnout
2025-02-28 00:00:008-KStáhnout
2025-02-28 00:00:0010-KStáhnout
2025-02-27 23:00:008-KStáhnout
2025-02-27 23:00:0010-KStáhnout
2025-01-29 00:00:008-KStáhnout
2025-01-28 23:00:008-KStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-06 00:00:0010-QStáhnout
2024-11-05 23:00:008-KStáhnout
2024-11-05 23:00:0010-QStáhnout
2024-10-15 01:00:008-KStáhnout
2024-10-15 00:00:008-KStáhnout
2024-09-03 01:00:008-KStáhnout
2024-09-03 00:00:008-KStáhnout
2024-08-13 01:00:008-KStáhnout
2024-08-13 01:00:0010-QStáhnout
2024-08-13 00:00:008-KStáhnout
2024-08-13 00:00:0010-QStáhnout
2024-06-06 01:00:008-KStáhnout
2024-06-06 00:00:008-KStáhnout
2024-05-13 01:00:008-KStáhnout
2024-05-13 01:00:0010-QStáhnout
2024-05-13 00:00:008-KStáhnout
2024-05-13 00:00:0010-QStáhnout
2024-03-29 00:00:008-KStáhnout
2024-03-28 23:00:008-KStáhnout
2024-03-26 00:00:008-KStáhnout
2024-03-25 23:00:008-KStáhnout
2024-03-05 00:00:008-KStáhnout
2024-03-05 00:00:0010-KStáhnout
2024-03-04 23:00:008-KStáhnout
2024-03-04 23:00:0010-KStáhnout
2024-01-12 00:00:008-KStáhnout
2024-01-11 23:00:008-KStáhnout
2024-01-11 00:00:008-KStáhnout
2024-01-10 23:00:008-KStáhnout
2024-01-10 00:00:008-KStáhnout
2024-01-09 23:00:008-KStáhnout
2023-12-07 00:00:008-KStáhnout
2023-12-06 23:00:008-KStáhnout
2023-12-01 00:00:008-KStáhnout
2023-11-30 23:00:008-KStáhnout
2023-11-22 00:00:008-KStáhnout
2023-11-21 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-11-06 00:00:008-KStáhnout
2023-11-05 23:00:008-KStáhnout
2023-10-02 01:00:008-KStáhnout
2023-10-02 00:00:008-KStáhnout
2023-08-09 01:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:008-KStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-06-20 01:00:008-KStáhnout
2023-06-20 00:00:008-KStáhnout
2023-06-16 01:00:008-KStáhnout
2023-06-16 00:00:008-KStáhnout
2023-06-14 01:00:008-KStáhnout
2023-06-14 00:00:008-KStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-11 01:00:008-KStáhnout
2023-05-11 01:00:0010-QStáhnout
2023-05-11 00:00:008-KStáhnout
2023-05-11 00:00:0010-QStáhnout
2023-04-17 01:00:008-KStáhnout
2023-04-17 00:00:008-KStáhnout
2023-03-21 00:00:008-KStáhnout
2023-03-20 23:00:008-KStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-03-03 00:00:008-KStáhnout
2023-03-02 23:00:008-KStáhnout
2023-02-07 00:00:008-KStáhnout
2023-02-07 00:00:0010-KStáhnout
2023-02-06 23:00:008-KStáhnout
2023-02-06 23:00:0010-KStáhnout
2022-11-28 00:00:008-KStáhnout
2022-11-27 23:00:008-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-09-07 01:00:008-KStáhnout
2022-09-07 00:00:008-KStáhnout
2022-08-12 01:00:008-KStáhnout
2022-08-12 00:00:008-KStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-07-26 01:00:008-KStáhnout
2022-07-26 00:00:008-KStáhnout
2022-06-06 01:00:008-KStáhnout
2022-06-06 00:00:008-KStáhnout
2022-06-01 01:00:008-KStáhnout
2022-06-01 00:00:008-KStáhnout
2022-05-23 01:00:008-KStáhnout
2022-05-23 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-04-29 01:00:008-KStáhnout
2022-04-29 00:00:008-KStáhnout
2022-04-27 01:00:008-KStáhnout
2022-04-27 00:00:008-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-28 00:00:0010-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-02-27 23:00:0010-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2022-01-07 00:00:008-KStáhnout
2022-01-06 23:00:008-KStáhnout
2021-12-17 00:00:008-KStáhnout
2021-12-16 23:00:008-KStáhnout
2021-11-03 00:00:008-KStáhnout
2021-11-03 00:00:0010-QStáhnout
2021-11-02 23:00:008-KStáhnout
2021-11-02 23:00:0010-QStáhnout
2021-08-30 01:00:008-KStáhnout
2021-08-30 00:00:008-KStáhnout
2021-08-16 01:00:008-KStáhnout
2021-08-16 01:00:0010-QStáhnout
2021-08-16 00:00:008-KStáhnout
2021-08-16 00:00:0010-QStáhnout
2021-06-10 01:00:008-KStáhnout
2021-06-10 00:00:008-KStáhnout
2021-06-02 01:00:008-KStáhnout
2021-06-02 00:00:008-KStáhnout
2021-05-25 01:00:008-KStáhnout
2021-05-25 00:00:008-KStáhnout
2021-05-11 01:00:008-KStáhnout
2021-05-11 01:00:0010-QStáhnout
2021-05-11 00:00:008-KStáhnout
2021-05-11 00:00:0010-QStáhnout
2021-04-29 01:00:008-KStáhnout
2021-04-29 00:00:008-KStáhnout
2021-04-15 01:00:008-KStáhnout
2021-04-15 00:00:008-KStáhnout
2021-03-17 00:00:008-KStáhnout
2021-03-17 00:00:0010-KStáhnout
2021-03-16 23:00:008-KStáhnout
2021-03-16 23:00:0010-KStáhnout
2020-12-01 00:00:008-KStáhnout
2020-11-30 23:00:008-KStáhnout
2020-11-23 00:00:0010-QStáhnout
2020-11-22 23:00:0010-QStáhnout
2020-11-17 00:00:008-KStáhnout
2020-11-16 23:00:008-KStáhnout
2020-11-10 00:00:008-KStáhnout
2020-11-09 23:00:008-KStáhnout
2020-10-20 01:00:008-KStáhnout
2020-10-20 00:00:008-KStáhnout
preloader